Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998618 · ClinicalTrials.gov registry record · NA
Telephone Support for Metastatic Breast Cancer Patients
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT03998618 is a NA study that has completed, run by Indiana University. The registered enrollment target is 250 participants.
The verdict
NCT03998618, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
This trial tests telephone-based Acceptance and Commitment Therapy (ACT), a type of psychotherapy, to reduce fatigue interference with activities, mood, and cognition in metastatic breast cancer (MBC) cancer patients. ACT includes mindfulness exercises (e.g., meditations, performing activities with greater awareness), identifying personal values (e.g., family, work), and engaging in activities consistent with these values. A total of 250 patients will be randomly assigned in equal numbers to either the ACT intervention or an education/support condition. Patients in both conditions will participate in six weekly 50-minute telephone sessions. Outcomes will be assessed at baseline, 2 weeks post-intervention, and 3 and 6 months post-intervention. The investigators hypothesize that ACT will lead to improved primary and secondary outcomes as compared to education/support. A demonstration of ACT's efficacy will lead to dissemination of the intervention and ultimately fulfill an unmet need in the comprehensive care of MBC patients.
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- BEHAVIORAL Education/Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2023-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03998618
The ClinicalTrials.gov registry entry for NCT03998618 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT03998618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03998618 about?
NCT03998618 is a clinical study titled "Telephone Support for Metastatic Breast Cancer Patients". This trial tests telephone-based Acceptance and Commitment Therapy (ACT), a type of psychotherapy, to reduce fatigue interference with activities, mood, and cognition in metastatic breast cancer (MBC) cancer patients. ACT includes mindfulness exercises (e.g., meditations, performing activities with ...
What is the current status of trial NCT03998618?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2019-06-20. Estimated completion is 2023-09-13.
What interventions are being tested in trial NCT03998618?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Education/Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT03998618?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.